---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-000910"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2024-06-18T23:59:59+00:00"
generated_at: "2026-06-01T03:52:30.376736+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nutex Health receives Nasdaq exception until July 22 to effect reverse stock split and regain $1 bid price

## Summary
- Nasdaq Hearings Panel granted Nutex exception until July 22, 2024 to execute reverse split and regain $1.00 minimum bid.
- Stockholders approved reverse stock split (1-for-2 to 1-for-16); board to set exact ratio within one year.
- Company had already done a 1-for-15 reverse split in April 2024 but still not compliant; delisting if not cured by July 22.
- Annual meeting also elected all director nominees, approved executive compensation, and ratified Marcum LLP as auditor for FY2024.

## SEC filing metadata
- accession: 0001079973-24-000910
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2024-06-18T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000107997324000910/0001079973-24-000910-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000107997324000910/nutx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-000910
- JSON: https://secwatch.observer/filing/0001079973-24-000910.json
- Plain text: https://secwatch.observer/filing/0001079973-24-000910.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.